Records containing: Rectal Adenocarcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-29Feasibility of Dose-Escalated Short-Course Proton Therapy for Locally Advanced Rectal Cancer: A National Multicentre Feasibility Study to Prepare a Phase III Randomised Trial
-
CLINICAL_TRIALS study record update · 2026-10-06Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease
-
CLINICAL_TRIALS study record update · 2026-09-14ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
-
CLINICAL_TRIALS study record update · 2026-04-24Short-Course Radiotherapy Combined With mFOLFOX6, PD-1 Antibody and Cetuximab (for RAS/BRAF Wild-Type)/Bevacizumab (for RAS/BRAF Mutant) in High-Risk pMMR/MSS Rectal Adenocarcinoma: a Phase III Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-22A Prospective, Multicenter, Single-Arm Phase II Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (cT1-3N0M0)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 Versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase II Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
-
CLINICAL_TRIALS study record update · 2026-04-16Young-Onset Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2026-04-15Phase 1b Study to Assess the Safety of Neoadjuvant TAS-102 (Trifluridine/Tipiracil) With Concurrent Radiation in Previously Untreated Resectable Stage II and Stage III Rectal Cancer (FIERCE)
-
CLINICAL_TRIALS study record update · 2026-04-13Phase II Study of TGFβ Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-04-06Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
-
CLINICAL_TRIALS study record update · 2026-04-06Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer
-
CLINICAL_TRIALS study record update · 2026-04-01MRI Guided Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma to Enhance Complete Response
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase II Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2026-03-30Organ Preservation for Patients With Locally Advanced Rectal Adenocarcinoma: Evaluating the Efficacy of Short Course Radiation Therapy Followed by FOLFOX or CapeOX
-
CLINICAL_TRIALS study record update · 2026-03-16MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
-
CLINICAL_TRIALS study record update · 2026-03-05INTERPRETE: a Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Organ Sparing and Mininvasivity
-
CLINICAL_TRIALS study record update · 2026-03-04A Phase II Study of Induction Tucatinib and Trastuzumab With Total Neoadjuvant Therapy for Locally Advanced HER2-amplified Rectal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-02-24A Phase 1/2, Open-Label, Dose-Escalation and Expansion First-In-Human Study of ATX-559, an Oral Inhibitor of the Helicase DHX9, in Patients With Locally Advanced or Metastatic Solid Tumors and Molecularly Defined Cancers
-
CLINICAL_TRIALS study record update · 2026-02-18Adoption of Advanced Endoscopic Resection Methods in the Treatment of Rectal Neoplasms
-
CLINICAL_TRIALS study record update · 2026-02-17Phase II Single Arm Study of Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer: the CHIMERA Study.
-
CLINICAL_TRIALS study record update · 2026-02-06Surveillance Digital Rectoscopy After Local Excision of Rectal Tumours
-
CLINICAL_TRIALS study record update · 2026-01-23A Phase II Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-01-22Use of Text Messages to Increase Whole Grain Consumption in Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2026-01-20ULtra sensiTive ctDNA-Informed Management eArly-stage recTal cancEr (ULTIMATE)